Business Wire

THALES

8.10.2019 12:59:03 CEST | Business Wire | Press release

Share
Thales Study: Organizations Worldwide Failing to Adequately Protect Sensitive Data in the Cloud

A new global study from Thales , with research from the Ponemon Institute, has exposed an increasing disparity between the rapid growth of data stored in the cloud and an organization’s approach to cloud security. Although nearly half (48%) of corporate data is stored in the cloud, only a third (32%) of organizations admit they employ a security-first approach to data storage in the cloud.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191008005492/en/

Surveying over 3,000 IT and IT security practitioners in Australia, Brazil, France, Germany, India Japan, the United Kingdom and the United States, the research found that only one in three (31%) organizations believe that protecting data in the cloud is their own responsibility.

Increased multi-cloud cloud use, but with risks

With the proliferation of cloud-based services, businesses and other organizations are increasingly dependent on cloud providers. In fact, nearly half (48%) of organizations have a multi-cloud strategy, with Amazon Web Services (AWS), Microsoft Azure and IBM being the top three. The study found that, on average, organizations use three different cloud service providers and over a quarter (28%) are using four or more.

Despite storing sensitive data in the cloud, nearly half (46%) surveyed revealed that storing consumer data in the cloud makes them more of a security risk. Over half (56%) also noted that it posed a compliance risk. In addition, organizations believe that cloud service providers bear the most responsibility for sensitive data in the cloud (35%), ahead of shared responsibility (33%) and themselves (31%). Even though businesses are pushing the responsibility to cloud providers, only 23% say security is a factor in selecting them.

“With businesses increasingly looking to use multiple cloud platforms and providers, it’s vital they understand what data is being stored and where,” said Larry Ponemon, chairman and founder of the Ponemon Institute. “Not knowing this information makes it essentially impossible to protect the most sensitive data --ultimately leaving these organizations at risk. We’d encourage all companies to take responsibility for understanding where their data sits to ensure it’s safe and secure.”

Encryption increasing, but organizations handing over keys to cloud providers

Roughly half (51%) of businesses and other organizations still do not use encryption or tokenization to protect sensitive data in the cloud. The study uncovered regional disparities in terms of data security, with German organizations being the most advanced in their use of encryption at 66%.

Organizations are handing over the keys to their encrypted data to cloud providers. Nearly half of cloud companies (44%) provide the encryption keys when data is encrypted in the cloud, ahead of in-house teams (36%) and third parties (19%). On top of this, 53% are controlling these encryption keys themselves, despite 78% saying it’s important their organization retains control of the keys.

Over half of businesses (54%) think cloud storage makes it more difficult to protect sensitive data, up from 49% last year. More than 70% believe that data in a cloud environment is harder to protect due to the complexity of managing privacy and data protection regulations, while an additional two-thirds (67%) cited the difficulty of applying conventional security methods in the cloud.

“This study shows that businesses today are taking advantage of the opportunities that new cloud options offer, but aren’t adequately addressing data security,” said Tina Stewart, vice president of market strategy for cloud protection and licensing activity at Thales . “Having pushed the responsibility towards cloud providers, it is surprising to see that security is not a primary factor during the selection process. It doesn’t matter what model or provider you choose, the security of your business’ data in the cloud has to be your responsibility. Your organization’s reputation is on the line when a data breach occurs, so it is critical to ensure in-house teams keep a close eye on your security posture and always retain control of encryption keys.”

For more information, attend our “Global Trends in Cloud Security: Gaps in Security Persist in a Multi-Cloud World” webinar taking place on November 7 or visit the 2019 Thales Cloud Security Study website .

Research methodology

This research was conducted by the Ponemon Institute on behalf of Thales with 3,667 IT and IT security practitioners surveyed across the Australia, Brazil, France, Germany, India, Japan, the United Kingdom and the United States.

Industry insight and views on the latest data security trends can be found on the Thales blog at blog.thalesesecurity.com .

Follow Thales on Twitter , LinkedIn , Facebook and YouTube .

About Thales

Thales (Euronext Paris: HO) is a global technology leader shaping the world of tomorrow today. The Group provides solutions, services and products to customers in the aeronautics, space, transport, digital identity and security, and defence markets. With 80,000 employees in 68 countries, Thales generated sales of €19 billion in 2018 (on a pro forma basis including Gemalto).

Thales is investing in particular in digital innovations — connectivity, Big Data, artificial intelligence and cybersecurity — technologies that support businesses, organisations and governments in their decisive moments

PLEASE VISIT
Thales Group
Security
Download HD photos

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye